Limertinib is intended for the treatment of patients with lung cancer. Credit: New Africa/Shutterstock. Innovent Biologics and Jiangsu Aosaikang Pharmaceutical (ASK Pharm) have signed a
The mpox vaccine is approved in in Canada, the European Union, Mexico, Singapore, Switzerland, the UK and the US. Credit: Creative Design nacional/Shutterstock. Bavarian Nordic
Through this partnership, the companies intend to innovate new therapeutics and expedite the drug discovery and development process. Credit: Volha_R/Shutterstock. Generate:Biomedicines and Novartis have entered
FRUZAQLA is intended for patients with CRC that has progressed following chemotherapy. Credit: SewCreamStudio/Shutterstock. Takeda has secured approval from the Japanese Ministry of Health, Labour
The CHMP positive opinion for AstraZeneca’s Fasenra as an add-on treatment was based on results from the Phase III MANDARA trial. Credit: Konektus Photo/Shutterstock. The
The product is indicated to treat active psoriatic arthritis, non-radiographic axial spondyloarthritis and ankylosing spondylitis. Credit: Oporty786/Shutterstock. Biopharmaceutical company UCB has received US Food and
The cream is indicated for use by chronic hand eczema patients for whom topical corticosteroids are not suitable. Credit: Ladanifer/Shutterstock. The European Commission (EC) has
The agreement will allow Lupin to expand its gastroenterology portfolio in the Indian market. Credit: Orawan Pattarawimonchai/Shutterstock. Pharmaceutical company Lupin has announced a non-exclusive patent
HERCESSI is approved for treating HER2-overexpressing breast cancer, metastatic breast cancer, and metastatic gastric or gastroesophageal junction adenocarcinoma. Credit: Lightspring/Shutterstock. Accord BioPharma, the speciality division
Bavarian Nordic recently made a filing with the European Medicines Agency seeking to extend the vaccine’s approval to adolescents. Credit: angellodeco/Shutterstock. Gavi (the Global Alliance